.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Accenture
US Army
Cipla
Chubb
Daiichi Sankyo
UBS
AstraZeneca
Express Scripts

Generated: June 25, 2017

DrugPatentWatch Database Preview

CLEMASTINE FUMARATE Drug Profile

« Back to Dashboard

What is the patent landscape for Clemastine Fumarate, and when can generic versions of Clemastine Fumarate launch?

Clemastine Fumarate is a drug marketed by Apotex Inc, L Perrigo Co, Sandoz, Wockhardt, Actavis Mid Atlantic, Ani Pharms Inc, Teva, Silarx, and Teva Pharms. and is included in eleven NDAs.

The generic ingredient in CLEMASTINE FUMARATE is clemastine fumarate. There are two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.

Summary for Tradename: CLEMASTINE FUMARATE

Patents:0
Applicants:9
NDAs:11
Suppliers / Packagers: see list16
Bulk Api Vendors: see list54
Clinical Trials: see list535
Patent Applications: see list4,359
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLEMASTINE FUMARATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
CLEMASTINE FUMARATE
clemastine fumarate
SYRUP;ORAL075703-001Nov 27, 2000DISCNNoNo► Subscribe► Subscribe
Ani Pharms Inc
CLEMASTINE FUMARATE
clemastine fumarate
TABLET;ORAL073282-001Jan 31, 1992DISCNNoNo► Subscribe► Subscribe
Sandoz
CLEMASTINE FUMARATE
clemastine fumarate
TABLET;ORAL073459-001Oct 31, 1993DISCNNoNo► Subscribe► Subscribe
Teva
CLEMASTINE FUMARATE
clemastine fumarate
SYRUP;ORAL073399-001Jun 30, 1994AARXNoYes► Subscribe► Subscribe
Ani Pharms Inc
CLEMASTINE FUMARATE
clemastine fumarate
TABLET;ORAL073282-002Dec 3, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Moodys
Baxter
Accenture
Medtronic
Colorcon
Cipla
Teva
QuintilesIMS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot